AGRF Partners with Integrated Sciences to Offer Cutting-Edge Epigenetic Services with EpiCypher CUT&RUN and CUT&Tag Technologies
Posted: 5 December 2024 AGRF (Australian Genome Research Facility Ltd) and Integrated Sciences are excited to announce a new partnership that will bring advanced genomics capabilities to researchers across Australia and New Zealand. This collaboration will enable AGRF’s…
INOVIQ completes disease specificity testing for breast cancer
Posted: 5 December 2024 INOVIQ Limited (ASX:IIQ or INOVIQ) is pleased to announce the successful completion of disease specificity testing for breast cancer. The INOVIQ blood test is a simple, accurate and affordable immunoassay developed using a monoclonal…
First Patient Dosed in Phase III ZIRCON-CP Trial of TLX250-CDx for Kidney Cancer Imaging in Chinese Patients
Posted: 4 December 2024 Telix and Grand Pharma today announce that a first patient has been dosed in the Phase III ZIRCON-CP trial of TLX250-CDx positron emission tomography (PET) imaging of clear cell renal cell carcinoma (ccRCC). The…
Ovarian Cancer Test Delivers Outstanding Diagnostic Performance
Posted: 4 December 2024 INOVIQ Limited (ASX:IIQ or INOVIQ) is pleased to announce that its blood test for ovarian cancer screening has successfully completed an independent patient validation of its biomarkers and diagnostic performance, delivering outstanding test results…
LSQ Honours Visionary Biotech Leader with Hall of Fame Award
Posted: 4 December 2024 Before her death from cancer in August his year, Dr Depaz was Country Medical Lead and Head of Medical Vaccines for Sanofi Australia & New Zealand, as well as Managing Director of the Translational…
Sir Gustav Nossal Professor of Immunology to honour giant of Australian science
Posted: 4 December 2024 The exceptional research, discovery and advocacy legacy of former WEHI director and Australian treasure Sir Gustav Nossal AC CBE will continue through an ongoing professorship, announced today by WEHI and the Nossal family. Launched with a…
Alterity Therapeutics Completes Last Patient Visit in ATH434-201 Phase 2 Clinical Trial in Early-Stage Multiple System Atrophy
Posted: 4 December 2024 Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that the last patient in the ATH434-201 Phase 2 trial,…
Optiscan inks deal with US uni to diagnose cancer in animals
Posted: 27 November 2024 Optiscan has been featured in Stockhead and The Australian regarding its partnership with the University of Minnesota to advance cancer detection in pets. This collaboration focuses on utilizing Optiscan’s confocal endomicroscope imaging system to…
Promising daily tablet increases growth in children with dwarfism
Posted: 27 November 2024 A promising daily tablet is effective at increasing height and improving proportional limb growth in children with achondroplasia, the most common form of dwarfism, according to a new study. And the findings could spare…
Moderna Announces The Awardees For Its 2024 Australia Fellowship Program, Supporting World-Class mRNA Science In Australia
Posted: 27 November 2024 Moderna, Inc (NASDAQ: MRNA), today announced the awardees of its 2024 Australia Fellowship Program. The program, in its second year, is dedicated to developing the country’s world-leading health and medical research sector in mRNA…
Immutep’s Efti Shows Excellent Survival Data from INSIGHT-003 Trial in Non-Small Cell Lung Cancer
Posted: 27 November 2024 Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces positive data from the investigator-initiated INSIGHT-003 Phase I trial evaluating…
Merck and Digital Trust Centre at NTU Singapore, collaborate to Enable Digital Trust
Posted: 27 November 2024 Merck, a leading science and technology company, and Digital Trust Centre (DTC) at Nanyang Technological University, Singapore (NTU Singapore) are collaborating to pioneer a new digital trust technology designed to enable secure, automated, traceable…
